3-(4-tert-butylbenzene-6-id-1-yl)-1-(2-methylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide;tetrakis(iridium);1-(2-methylphenyl)-3-phenyl-2H-benzimidazol-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyridin-2-ide

C80H68Ir4N12-8 — CID 159417650

IUPAC3-(4-tert-butylbenzene-6-id-1-yl)-1-(2-methylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide;tetrakis(iridium);1-(2-methylphenyl)-3-phenyl-2H-benzimidazol-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyridin-2-ide
SMILESCc1ccccc1N1[CH-]N(c2[c-]cc(C(C)(C)C)cc2)c2ncccc21.Cc1ccccc1N1[CH-]N(c2[c-]cccc2)c2ccccc21.Cc1ccccc1N1[CH-]N(c2[c-]cccc2)c2cccnc21.Cc1ccccc1N1[CH-]N(c2[c-]cccc2)c2nccnc21.[Ir].[Ir].[Ir].[Ir]
InChIInChI=1S/C23H23N3.C20H16N2.C19H15N3.C18H14N4.4Ir/c1-17-8-5-6-9-20(17)26-16-25(22-21(26)10-7-15-24-22)19-13-11-18(12-14-19)23(2,3)4;1-16-9-5-6-12-18(16)22-15-21(17-10-3-2-4-11-17)19-13-7-8-14-20(19)22;1-15-8-5-6-11-17(15)22-14-21(16-9-3-2-4-10-16)18-12-7-13-20-19(18)22;1-14-7-5-6-10-16(14)22-13-21(15-8-3-2-4-9-15)17-18(22)20-12-11-19-17;;;;/h5-13,15-16H,1-4H3;2-10,12-15H,1H3;2-9,11-14H,1H3;2-8,10-13H,1H3;;;;/q4*-2;;;;
InChIKeyVGRRMKUQFSNOQJ-UHFFFAOYSA-N
MW1966.38 g/mol
LogP19.68
Rot. Bonds8

About 3-(4-tert-butylbenzene-6-id-1-yl)-1-(2-methylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide;tetrakis(iridium);1-(2-methylphenyl)-3-phenyl-2H-benzimidazol-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyridin-2-ide

3-(4-tert-butylbenzene-6-id-1-yl)-1-(2-methylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide;tetrakis(iridium);1-(2-methylphenyl)-3-phenyl-2H-benzimidazol-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyridin-2-ide (PubChem CID 159417650) has the molecular formula C80H68Ir4N12-8 and a molecular weight of 1966.38 g/mol. Its IUPAC name is 3-(4-tert-butylbenzene-6-id-1-yl)-1-(2-methylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide;tetrakis(iridium);1-(2-methylphenyl)-3-phenyl-2H-benzimidazol-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyridin-2-ide.

Molecular Properties

Compound Name3-(4-tert-butylbenzene-6-id-1-yl)-1-(2-methylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide;tetrakis(iridium);1-(2-methylphenyl)-3-phenyl-2H-benzimidazol-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyridin-2-ide
PubChem CID159417650
Molecular FormulaC80H68Ir4N12-8
Molecular Weight1966.38 g/mol
Exact Mass1968.43
IUPAC Name3-(4-tert-butylbenzene-6-id-1-yl)-1-(2-methylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide;tetrakis(iridium);1-(2-methylphenyl)-3-phenyl-2H-benzimidazol-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyridin-2-ide
SMILESCc1ccccc1N1[CH-]N(c2[c-]cc(C(C)(C)C)cc2)c2ncccc21.Cc1ccccc1N1[CH-]N(c2[c-]cccc2)c2ccccc21.Cc1ccccc1N1[CH-]N(c2[c-]cccc2)c2cccnc21.Cc1ccccc1N1[CH-]N(c2[c-]cccc2)c2nccnc21.[Ir].[Ir].[Ir].[Ir]
InChIInChI=1S/C23H23N3.C20H16N2.C19H15N3.C18H14N4.4Ir/c1-17-8-5-6-9-20(17)26-16-25(22-21(26)10-7-15-24-22)19-13-11-18(12-14-19)23(2,3)4;1-16-9-5-6-12-18(16)22-15-21(17-10-3-2-4-11-17)19-13-7-8-14-20(19)22;1-15-8-5-6-11-17(15)22-14-21(16-9-3-2-4-10-16)18-12-7-13-20-19(18)22;1-14-7-5-6-10-16(14)22-13-21(15-8-3-2-4-9-15)17-18(22)20-12-11-19-17;;;;/h5-13,15-16H,1-4H3;2-10,12-15H,1H3;2-9,11-14H,1H3;2-8,10-13H,1H3;;;;/q4*-2;;;;
InChIKeyVGRRMKUQFSNOQJ-UHFFFAOYSA-N
XLogP19.68
TPSA77.48 Ų
H-Bond Donors
H-Bond Acceptors12
Rotatable Bonds8
Heavy Atoms96
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001966.38
LogP ≤ 519.68
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze 3-(4-tert-butylbenzene-6-id-1-yl)-1-(2-methylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide;tetrakis(iridium);1-(2-methylphenyl)-3-phenyl-2H-benzimidazol-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyridin-2-ide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-(4-tert-butylbenzene-6-id-1-yl)-1-(2-methylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide;tetrakis(iridium);1-(2-methylphenyl)-3-phenyl-2H-benzimidazol-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyridin-2-ide?
The IUPAC name of 3-(4-tert-butylbenzene-6-id-1-yl)-1-(2-methylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide;tetrakis(iridium);1-(2-methylphenyl)-3-phenyl-2H-benzimidazol-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyridin-2-ide (CID 159417650) is 3-(4-tert-butylbenzene-6-id-1-yl)-1-(2-methylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide;tetrakis(iridium);1-(2-methylphenyl)-3-phenyl-2H-benzimidazol-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyridin-2-ide.
What is the SMILES notation for 3-(4-tert-butylbenzene-6-id-1-yl)-1-(2-methylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide;tetrakis(iridium);1-(2-methylphenyl)-3-phenyl-2H-benzimidazol-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyridin-2-ide?
The canonical SMILES for 3-(4-tert-butylbenzene-6-id-1-yl)-1-(2-methylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide;tetrakis(iridium);1-(2-methylphenyl)-3-phenyl-2H-benzimidazol-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyridin-2-ide is Cc1ccccc1N1[CH-]N(c2[c-]cc(C(C)(C)C)cc2)c2ncccc21.Cc1ccccc1N1[CH-]N(c2[c-]cccc2)c2ccccc21.Cc1ccccc1N1[CH-]N(c2[c-]cccc2)c2cccnc21.Cc1ccccc1N1[CH-]N(c2[c-]cccc2)c2nccnc21.[Ir].[Ir].[Ir].[Ir].
What is the InChIKey of 3-(4-tert-butylbenzene-6-id-1-yl)-1-(2-methylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide;tetrakis(iridium);1-(2-methylphenyl)-3-phenyl-2H-benzimidazol-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyridin-2-ide?
The InChIKey is VGRRMKUQFSNOQJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H23N3.C20H16N2.C19H15N3.C18H14N4.4Ir/c1-17-8-5-6-9-20(17)26-16-25(22-21(26)10-7-15-24-22)19-13-11-18(12-14-19)23(2,3)4;1-16-9-5-6-12-18(16)22-15-21(17-10-3-2-4-11-17)19-13-7-8-14-20(19)22;1-15-8-5-6-11-17(15)22-14-21(16-9-3-2-4-10-16)18-12-7-13-20-19(18)22;1-14-7-5-6-10-16(14)22-13-21(15-8-3-2-4-9-15)17-18(22)20-12-11-19-17;;;;/h5-13,15-16H,1-4H3;2-10,12-15H,1H3;2-9,11-14H,1H3;2-8,10-13H,1H3;;;;/q4*-2;;;;.
What are the key properties of 3-(4-tert-butylbenzene-6-id-1-yl)-1-(2-methylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide;tetrakis(iridium);1-(2-methylphenyl)-3-phenyl-2H-benzimidazol-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyridin-2-ide?
3-(4-tert-butylbenzene-6-id-1-yl)-1-(2-methylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide;tetrakis(iridium);1-(2-methylphenyl)-3-phenyl-2H-benzimidazol-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyridin-2-ide has a molecular weight of 1966.38 g/mol, XLogP of 19.68, 8 rotatable bonds, 0 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for 3-(4-tert-butylbenzene-6-id-1-yl)-1-(2-methylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide;tetrakis(iridium);1-(2-methylphenyl)-3-phenyl-2H-benzimidazol-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyridin-2-ide is sourced from PubChem (CID 159417650), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).